Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Flower in connection with the acquisition of the energy storage facility Bredhälla from OX2
Mandate

Vinge has advised Flower in connection with the acquisition of the energy storage facility Bredhälla from OX2.

June 11, 2024 M&A Banking and Finance Environmental Law Commercial Agreements Real Estate and Construction FDI

The energy storage facility Bredhälla consists of batteries utilizing lithium-ion technology with a total capacity of 42,5MW /42,5MWh spread across 20 modules, making it the largest battery park in Sweden. Bredhälla will provide ancillary services to Svenska Kraftnät to ensure stability in the electricity grid and participate in wholesale markets by providing energy arbitrage.

The acquisition strengthens Flower’s position as the leading battery optimizer in Sweden.

Vinges team mainly consisted of Peter Sundgren and Gustav Wahlberg (M&A), Albert Wållgren and Jolinn Uhlin (Financing), Johan Cederblad and Lina Österberg (Environment), Jolene Reimersson and Carl Lexenberg (Commercial Agreements), Daniel Prawitz and Clara Klingspor (Construction) as well as Daniel Wendelsson, Felizia Wiker, Dagne Sabockis and Alva Chambert (FDI).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026